Paper · 7684608

Nature of the interaction of heparin with acidic fibroblast growth factor.

Mach H and 7 others. Biochemistry, 1993. Cited by 178 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. Nature of the interaction of heparin with acidic fibroblast growth factor. Papers, record 7684608. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7684608

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: Nature of the interaction of heparin with acidic fibroblast growth factor.; PubMed
Journal: Biochemistry; PubMed
Year: 1993; PubMed
Publication types: Journal Article, Research Support, U.S. Gov't, P.H.S.; PubMed
PubMed: https://pubmed.ncbi.nlm.nih.gov/7684608/; PubMed
DOI: https://doi.org/10.1021/bi00071a026; PubMed
The journal: https://conductscience.org/library/journal-index/0370623; PubMed
Citations, by iCite: 178; iCite
Relative citation ratio, by iCite: 4.38; iCite
Revised in PubMed: 2019-06-13; PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename
1	Mach H	H
2	Volkin DB	D B
3	Burke CJ	C J
4	Middaugh CR	C R
5	Linhardt RJ	R J
6	Fromm JR	J R
7	Loganathan D	D
8	Mattsson L	L

Source PubMed

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH term	Major
Fibroblast Growth Factor 1	Major topic
Heparin	Major topic
Binding Sites
Carbohydrate Sequence
Chemical Phenomena
Chemistry, Physical
Electrophoresis, Polyacrylamide Gel
Heparin Lyase
Humans
Light
Molecular Sequence Data
Molecular Weight
Oligosaccharides
Polysaccharide-Lyases
Scattering, Radiation
Ultracentrifugation

Source PubMed

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes it	Agency	Country	NIH project	Stated by
GM38060	NIGMS NIH HHS	United States	R01GM038060	PubMed and NIH

Source NIH RePORTER

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by33

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 178 citations.

PMID	Title	Journal	Year	In Papers	Source
32,150,181	Evaluation of top-down mass spectrometry and ion-mobility spectroscopy as a means of mapping protein-binding motifs within heparin chains.	Analyst	2020	https://conductscience.org/library/papers/32150181	PubMed
30,271,699	Impact of Temperature on Heparin and Protein Interactions.	Biochem Physiol	2018	https://conductscience.org/library/papers/30271699	PubMed
28,850,788	Tuning and Predicting Mesh Size and Protein Release from Step Growth Hydrogels.	Biomacromolecules	2017	https://conductscience.org/library/papers/28850788	PubMed
28,211,013	Electrostatic Forces as Dominant Interactions Between Proteins and Polyanions: an ESI MS Study of Fibroblast Growth Factor Binding to Heparin Oligomers.	J Am Soc Mass Spectrom	2017	https://conductscience.org/library/papers/28211013	PubMed
27,739,666	Heparin-Mimicking Polymers: Synthesis and Biological Applications.	Biomacromolecules	2016	https://conductscience.org/library/papers/27739666	PubMed
27,663,556	Gas-Phase Analysis of the Complex of Fibroblast GrowthFactor 1 with Heparan Sulfate: A Traveling Wave Ion Mobility Spectrometry (TWIMS) and Molecular Modeling Study.	J Am Soc Mass Spectrom	2017	https://conductscience.org/library/papers/27663556	PubMed
26,412,225	Interactions between nattokinase and heparin/GAGs.	Glycoconj J	2015	https://conductscience.org/library/papers/26412225	PubMed
25,043,635	Probing structurally altered and aggregated states of therapeutically relevant proteins using GroEL coupled to bio-layer interferometry.	Protein Sci	2014	https://conductscience.org/library/papers/25043635	PubMed
24,659,968	Protein comparability assessments and potential applicability of high throughput biophysical methods and data visualization tools to compare physical stability profiles.	Front Pharmacol	2014	https://conductscience.org/library/papers/24659968	PubMed
23,601,319	Cooperative heparin-mediated oligomerization of fibroblast growth factor-1 (FGF1) precedes recruitment of FGFR2 to ternary complexes.	Biophys J	2013	https://conductscience.org/library/papers/23601319	PubMed

1 to 10 of 33

See all 33 cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Gene	NCBI Gene ID	Linked by	In Genes
FGF1	2,246	PubTator's text mining	https://conductscience.org/library/genes/2246

Source NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7684608

GET https://conductscience.org/api/papers/v1/7684608/cited_by?page=2

API reference For AI assistants